The bulk of correlative studies describing enhanced expression or de novo synthesis of IGF2BP1 in human cancer and animal model provide strong evidence that IGF2BP1 serves important roles in controlling embryonic development, as well as functions as an oncogenic factor in most of cancers. The gene discussed is IGF2BP1; the disease is cancer.